Key result
Review highlights depression's impact on CAD quality of life and therapy effects on prognosis.
This review highlights the impact of depression on morbidity, mortality, and quality of life in patients with coronary artery disease, and discusses recent treatment trials.
May support depression screening in CAD; leaves open optimal therapy effects on prognosis.
Depression has been shown to be a risk factor for the development of coronary artery disease, morbidity and mortality after onset of coronary disease. This article reviews recent studies investigating these links and discusses the impact of depression on quality of life in patients with coronary artery disease. Recent trials of psycho- and pharmacotherapy in this population are discussed, along with the impact of treatment on prognosis and quality of life.
No takes yet. Share an insight, caveat, or question.
J. Robert Swenson (2004) conducted a review in Coronary artery disease and depression. Psycho- and pharmacotherapy was evaluated. This review highlights the impact of depression on quality of life in patients with coronary artery disease and discusses the effects of psycho- and pharmacotherapy on prognosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: